The Compensatory Alterations оf the Relaxability and Distensibility of the Myocardium at Weakening of Its Contractility
- Authors: Kapelko V.I.1
-
Affiliations:
- Smirnov Institute of Experimental Cardiology, Chazov National Medical Research Center for Cardiology
- Issue: Vol 54, No 3 (2023)
- Pages: 25-35
- Section: Articles
- URL: https://journals.rcsi.science/0301-1798/article/view/138971
- DOI: https://doi.org/10.31857/S0301179823030025
- EDN: https://elibrary.ru/OWYEDT
- ID: 138971
Cite item
Abstract
Abstract—The contractile function of the heart is carried out due to the coordinated interaction of the basic properties of the myocardium – distensibility, contractility and relaxability. Violation of myocardial contractility due to any reason creates a situation of chronic heart failure (CHF). The severity of CHF is determined by the ability of the circulatory system to a certain extent to compensate for the weakening of the contractility of the heart, the criterion of which is the value of the ejection fraction. The form of CHF with preserved ejection fraction is defined as diastolic dysfunction. It is the first stage of CHF, its distinctive features are delayed relaxation and increased diastolic pressure in the left ventricle. The review is devoted to the consideration of the structure of diastole in 4 types of CHF – ischemic heart disease in myocardial infarction or microinfarctions caused by isoproterenol, myocardial damage induced by doxorubicin and type 1 diabetes. A common sign of all types of CHF is an increase in myocardial extensibility and a slowdown in relaxation. It has been shown that they are based on a change in the properties of connectin (titin) – a sacromeric protein that connects the ends of myosin filaments with the boundaries of the sarcomere. Its properties determine the distensibility and relaxation of the myocardium, and these changes underlie the primary compensatory reaction of the heart at weakening its contractility. Also mechanisms are mobilized that increase the inflow to the heart and reduce peripheral resistance. The degree of their mobilization depends on the degree of reduction in myocardial contractility. Along with this, each form of CHF has its own specifics, which must be taken into account when choosing the means of therapy.
About the authors
V. I. Kapelko
Smirnov Institute of Experimental Cardiology, Chazov National Medical Research Center for Cardiology
Author for correspondence.
Email: valk69@yandex.ru
Russia, 121552, Moscow
References
- Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. Знакомьтесь: диастолическая сердечная недостаточность // Сердечная недостаточность 2000. Т. 1. С. 40.
- Болеева Г.С., Мочалов С.В., Тарасова О.С. Функциональные изменения артериальных сосудов при экспериментальном сахарном диабете 1 типа // Успехи физиологических наук, 2014. Т. 45. № 2. С. 20.
- Капелько В.И., Горина М.С., Новикова Н.А. Сравнительная оценка сокращения и расслабления сердечной мышцы при уменьшении концентрации кальция в перфузате, ацидозе и метаболической блокаде // В сб. “Метаболизм миокарда”. М.: Медицина, 1983. С. 45.
- Капелько В.И., Новикова Н.А. Функциональные признаки энергодефицитной и гипокальциевой недостаточности сердца // В сб. “Новое в кардиологии” (ред. Чазов Е.И.). М.: Медицина, 1985. С. 90.
- Капелько В.И. Редокс-регуляция ритма сердца // Биохимия. 2012. Т. 77. № 11. С. 1491.
- Капелько В.И., Лакомкин В.Л., Лукошкова Е.В. и др. Систематическое исследование сердца крыс при поражении изопротеренолом // Кардиология. 2014. Т. 54. № 3. С. 46.
- Капелько В.И. Роль титина в сократительной функции сердца (обзор) // Успехи физиологических наук. 2022. Т. 53. № 2. С. 1.
- Лакомкин В.Л., Абрамов А.А., Студнева И.М. и др. Ранние изменения энергетического метаболизма и изоформного состава и уровня фосфорилирования титина при диастолической дисфункции // Кардиология. 2020. Т. 60. № 2. С. 4.
- Лакомкин В.Л., Абрамов А.А., Лукошкова Е.В., Капелько В.И. Гемодинамика и сократительная функция сердца при диабете 1 типа // Кардиология. 2022. Т. 62. № 8. С.33.
- Студнева И.М., Лакомкин В.Л., Просвирнин А.В. и др. Энергетический статус миокарда при систолической дисфункции // Кардиологический вестник. 2018. № 3. С. 31.
- Allawadhi P., Khurana A., Sayed N., Kumari P., Godugu C. Isoproterenol-induced cardiac ischemia and fibrosis: Plant-based approaches for intervention // Phytother. Res. 2018. V. 32. № 10б. P. 1908. https://doi.org/10.1002/ptr.6152
- Baseler W.A., Dabkowski E.R., Williamson C.L. et al. Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: Contribution of protein import dysfunction // Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011. V. 300. P. R186. https://doi.org/10.1152/ajpregu.00423.2010
- Beznak M., Hacker P. Hemodynamics during the chronic stage of myocardial damage caused by isoproterenol // Can. J. Physiol. Pharmacol. 1964. V. 42. P. 269.
- Brecher G.A. Experimental evidence of ventricular diastolic suction // Circ. Res. 1956. V. 4. P. 513. https://doi.org/10.1161/01.res.4.5.513
- Brooks W.W., Conrad C.H. Isoproterenol-Induced Myocardial Injury and Diastolic Dysfunction in Mice: Structural and Functional Correlates // Comp. Med. 2009. V. 59. № 4. P. 339.
- Bugger H., Chen D., Riehle C. et al. Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice // Diabetes. 2009. V. 58. P. 1986. https://doi.org/10.2337/db09-0259
- Cazorla O., Freiburg A., Helmes M. et al. Differential expression of cardiac titin isoforms and modulation of cellular stiffness // Circ. Res. 2000. V. 86. № 1. P. 59.
- Ceriello A., Quagliaro L., D’Amico M. et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat // Diabetes 2002. V. 51. № 4. P. 1076. PMID: . https://doi.org/10.2337/diabetes.51.4.107611916928
- Chung C.S., Granzier H.L. Contribution of titin and extracellular matrix to passive pressure and measurement of sarcomere length in the mouse left ventricle // J. Mol. Cell Cardiol. 2011. V. 50. № 4. P. 731. https://doi.org/10.1016/j.yjmcc.2011.01.005
- Cieluch A., Uruska A., Zozulinska-Ziolkiewicz D. Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options // International Journal of Molecular Sciences 2020. V. 21. P. 2852. https://doi.org/10.3390/ijms21082852
- Clementi M.E., Giardina B., Di Stasio E., Mordente A., Misiti F. Doxorubicin-derived metabolites induce release of cytochrome C and inhibition of respiration on cardiac isolated mitochondria // Anticancer Res. 2003. V. 23. P. 2445. PMID: 12894526
- Croston T.L., Shepherd D.L., Thapa D. et al. Evaluation of the cardiolipin biosynthetic pathway and its interactions in the diabetic heart // Life Sci. 2013. V. 93. P. 313. https://doi.org/10.1016/j.lfs.2013.07.005
- Eskander M., Kern M.J. Invasive Hemodynamics of Myocardial Disease: Systolic and Diastolic Dysfunction (and Hypertrophic Obstructive Cardiomyopathy // Interv. Cardiol. Clin. 2017. V. 6. № 3. P. 297. https://doi.org/10.1016/j.iccl.2017.03.001
- Farr G., Shah K., Markley R. et al. Development of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction // Prog. Cardiovasc. Dis. 2010. V. 59. № 1. P. 52. https://doi.org/10.1016/j.pcad.2016.06.002.
- Feng W., Li W. The study of ISO induced heart failure rat model // Exp. Mol. Pathol. V. 2010. № 88. P. 299. https://doi.org/10.1016/j.yexmp.2009.10.011
- Frederiksen J.W., Weiss J.L., Weisfeldt M.L. Time constant of isovolumic pressure fall: determinants in the working left ventricle // Am. J. Physiol. 1978. V. 235. P. H701.
- Fujita H., Labeit D., Gerull B., Labeit S., Granzier H.L. Titin isoform-dependent effect of calcium on passive myocardial tension // Am. J. Physiol. Heart. Circ. Physiol. 2004. V. 287. № 6. P. H2528.
- Fukuda N., Sasaki D., Ishiwata S., Kurihara S. Length dependence of tension generation in rat skinned cardiac muscle: role of titin in the Frank-Starling mechanism of the heart // Circulation. 2001. V. 104. P. 1639.
- Fukuda N., Wu Y., Nair P., Granzier H.L. Phosphorylation of titin modulates passive stiffness of cardiac muscle in a titin isoform dependent manner // J. Gen. Physiol. 2005. V. 125. P. 257. PMID: 15738048
- Gerber Y., Weston S.A., Berardi C. et al. Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study // Am. J. Epidemiol. 2013. V. 178. P. 1272.
- Gille L., Nohl H. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity // Free Radic. Biol. Med. 1997. V. 23. P. 775. https://doi.org/10.1016/s0891-5849(97)00025-7
- Granzier H.L., Irving T.C. Passive Tension in Cardiac Muscle: Contribution of Collagen, Titin, Microtubules, and Intermediate Filaments // Biophysical Journal. 1995. V. 68. P. 1027.
- Granzier H., Helmes M., Trombitas K. Nonuniform Elasticity of Titin in Cardiac Myocytes: A Study Using Immunoelectron Microscopy and Cellular Mechanics // Biophysical Journal. 1996. V. 70. P. 430. https://doi.org/10.1016/S0006-3495(96)79586-3
- Granzier H.L., Labeit S. The giant protein titin: a major player in myocardial mechanics, signaling, and disease // Circ. Res. 2004. V. 94. P. 284. https://doi.org/10.1161/01.RES.0000117769.88862.F8
- Helmes M., Trombitas K., Granzier H. Titin develops restoring force in rat cardiac myocytes // Circ. Res. 1996. V. 79. P. 619. https://doi.org/10.1161/01.res.79.3.619
- Hershko C., Pinson A., Link G. Prevention of anthracycline cardiotoxicity by iron chelation // Acta Haematol. 1996. V. 95. P. 87. https://doi.org/10.1159/000203954
- Katz L.N. The role played by the ventricular relaxation process in filling the ventricle // Am. J. Physiol. 1930. V. 95. P. 542.
- Kelly R.P., Ting C.T., Yang T.M. et al. Effective arterial elastance as index of arterial vascular load in humans // Circulation. 1992. V. 86. № 2. P. 513. PubMed: 1638719]9
- Ladeiras-Lopes R., Ferreira-Martins J., Leite-Moreira A.F. Acute neurohumoral modulation of diastolic function // Peptides. 2009. V. 30. P. 419.
- Lam C.S., Roger V.L., Rodeheffer R.J. et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study // J. Am. Coll. Cardiol. 2009. V. 53. № 13. P. 1119. https://doi.org/10.1016/j.jacc.2008.11.051
- Maruyama K., Natori R., Nonomura Y. New Elastic Protein From Muscle // Nature. 1976. V. 262. № 5563. P. 58. https://doi.org/10.1038/262058a0
- Marwick T.H. Ejection Fraction Pros and Cons: JACC State-of-the-Art Review // J. Am. Coll. Cardiol 2018. V. 72. № 19. P. 2360. https://doi.org/10.1016/j.jacc.2018.08.2162
- Matsuyoshi Y.N., Nishiyama A., Takaki M. et al. Left ventricular function of isoproterenol-induced hypertrophied rat hearts perfused with blood: mechanical work and energetics // Am. J. Physiol. Heart Circ. Physiol 2009. V. 297. P. H1736.
- Olson R.D., Mushlin P.S. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses // FASEB J. 1992. V. 4. P. 3076. PMID: 2210154
- Pham T., Loiselle D., Power A., Hickey A.J. Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart // Am. J. Physiol. Cell Physiol. 2014. V. 307. P. C499. https://doi.org/10.1152/ajpcell.00006.2014
- Preetha N., Yiming W., Helmes M. et al. Restoring force development by titin/connectin and assessment of Ig domain unfolding // J. Muscle Res. Cell Motil. 2005. V. 26. P. 307. https://doi.org/10.1007/s10974-005-9037-2
- Prunier F., Gaertner R., Louedec L. et al. Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats // Am. J. Physiol. Heart Circ. Physiol 2002. V. 283. P. H346.
- Rona G., Chappel G.I., Balazs T., Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat // Arch. Pathol. 1959. V. 67. P. 443.
- Rona G. Catecholamine cardiotoxicity // J. Mol. Cell. Cardiol. 1985. V. 17. № 4. P. 291. PMID: https://doi.org/10.1016/s0022-2828(85)80130-93894676
- Sarvazyan N. Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes // Am. J. Physiol. 1996. V. 271. P. H2079. https://doi.org/10.1152/ajpheart.1996.271.5.H2079
- Schnell O., Cappuccio F., Genovese S. et al. Type 1 diabetes and cardiovascular disease // Cardiovasc Diabetol. 2013. V. 28. № 12. P. 156. PMID: PMCID: PMC3816572 https://doi.org/10.1186/1475-2840-12-15624165454
- Semaming Y., Kumfu S., Pannangpetch P., Chattipakorn S.C., Chattipakorn N. Protocatechuic acid exerts a cardioprotective effect in type 1 diabetic rats // J. Endocrinol. 2014. V. 223. P. 13. https://doi.org/10.1530/JOE-14-0273
- Shivu G.N., Phan T.T., Abozguia K. et al. Relationship between coronary microvascular dysfunction and cardiac energetics impairment in type 1 diabetes mellitus // Circulation. 2010. V. 121. № 10. P. 1209. https://doi.org/10.1161/CIRCULATIONAHA.109.873273
- Suga H., Goto Y., Igarashi Y. et al. Ventricular suction under zero source pressure for filling // Am. J. Physiol. Heart Circ. Physiol. 1986. V. 251. P. H47. https://doi.org/10.1152/ajpheart.1986.251.1.H47
- Sunagawa K., Maughan W.L., Burkhoff D., Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle // Am. J. Physiol. 1983. V. 245. № 5. Pt. 1. P. H773. https://doi.org/10.1152/ajpheart.1983.245.5.H773
- Takaki M. Cardiac mechanoenergetics for understanding isoproterenol-induced rat heart failure // Pathophysiology. 2012. V. 19. № 3. P. 163. https://doi.org/10.1016/j.pathophys.2012.04.004
- Trombitas K., Freiburg A., Centner T., Labeit S., Granzier H. Molecular Dissection of N2B Cardiac Titin’s Extensibility // Biophysical Journal. 1999. V. 77. P. 3189.
- Vachiéry J.L., Adir Y., Barberà J.A. et al. Pulmonary hypertension due to left heart diseases // J. Am. Coll Cardiol. 2013. V. 62. № 25. Suppl. P. 100. https://doi.org/10.1016/j.jacc.2013.10.033
- Wakami K., Ohte N., Sakata S., Kimura G. Myocardial radial strain in early diastole is useful for assessing left ventricular early diastolic function: comparison with invasive parameters // J. Am. Soc. Echocardiogr. 2008. V. 21. № 5. P. 446. https://doi.org/10.1016/j.echo.2007.08.002
- Yellin E.L., Hori M., Yoran C. et al. Left ventricular relaxation in the filling and non–filling intact canine heart // Am. J. Physiol. Heart Circ. Physiol. 1986. V. 250. P. H620. https://doi.org/10.1152/ajpheart.1986.250.4.H620
- Xia S., Bornfeldt K.E. Mouse models for studies of cardiovascular complications of type 1 diabetes // Ann. N Y Acad. Sci. 2007. V. 1103. P. 202. PMID: https://doi.org/10.1196/annals.1394.00417376839